Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells

References

• BursteinNLCorneal cytotoxicity of topically applied drugs, vehicles, and preservativesSurv Ophthalmol19802515306998034
   PubMed Web of Science ®Google Scholar
• AoyamaYMotokiMHashimotoMEffect of various anti-glaucoma eyedrops on human corneal epithelial cellsNippon Ganka Gakkai Zasshi2004108758315022429
   PubMedGoogle Scholar
• NoeckerRJHerrygersLAAnwaruddinRCorneal and conjunctival changes caused by commonly used glaucoma medicationsCornea20042349049615220734
   PubMed Web of Science ®Google Scholar
• GuenounJMBaudouinCRatPPaulyAWarnetJMBrignole-BaudouinFIn vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cellsInvest Ophthalmol Vis Sci2005462444245015980234
   PubMed Web of Science ®Google Scholar
• BaudouinCLabbéALiangHPaulyABrignole-BaudouinFPreservatives in eyedrops: the good, the bad, and the uglyProg Retin Eye Res20102931233420302969
   PubMed Web of Science ®Google Scholar
• PfisterRRBursteinNLThe effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope studyInvest Ophthalmol1976152462591262158
   PubMedGoogle Scholar
• ChouAHoriSTakaseMOcular toxicity of beta-blockers and benzalkonium chloride in pigmented rabbits: electrophysiological and morphological studiesJpn J Ophthalmol19852913232861303
   PubMed Web of Science ®Google Scholar
• de Saint JeanMDebbaschCBrignoleFRatPWarnetJMBaudouinCToxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cellsCurr Eye Res200020859410617908
   PubMed Web of Science ®Google Scholar
• IshibashiTYokoiNKinoshitaSComparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chlorideJ Glaucoma20031248649014646684
   PubMed Web of Science ®Google Scholar
• PisellaPJDebbaschCHamardPConjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro studyInvest Ophthalmol Vis Sci2004451360136815111589
   PubMed Web of Science ®Google Scholar
• BaudouinCRianchoLWarnetJMBrignoleFIn vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprostInvest Ophthalmol Vis Sci2007484123412817724196
   PubMed Web of Science ®Google Scholar
• NuytsRMPelsEGreveELThe effects of 5-fluorouracil and mitomycin C on the corneal endotheliumCurr Eye Res1992115655701505200
   PubMed Web of Science ®Google Scholar
• AyakiMYaguchiSIwasawaAKoideRCytotoxicity of eye drops with and without preservatives for human corneal endothelial cells, epithelial cells, and conjunctival epithelial cellsExp Clin Ophthalmol200836553559
   PubMed Web of Science ®Google Scholar
• AyakiMNodaYYaguchiSCytotoxicity of antiglaucoma eye drops for human corneal endothelial cellsNippon Ganka Gakkai Zasshi200911357658219489448
   PubMedGoogle Scholar
• SamplesJRBinderPSNayakSThe effect of epinephrine and benzalkonium chloride on cultured corneal endothelial and trabecular meshwork cellsExp Eye Res1989491122759185
   PubMed Web of Science ®Google Scholar
• BaratzKHNauCBWinterEJEffects of glaucoma medications on corneal endothelium, keratocytes, and subbasal nerves among participants in the ocular hypertension treatment studyCornea2006251046105217133051
   PubMed Web of Science ®Google Scholar
• AyakiMShimadaKYaguchiSKoideRIwasawaACorneal and conjunctival toxicity of disinfectants–assessing safety for use with ophthalmic surgical instrumentsRegul Toxicol Pharmacol20074829229517517456
   PubMed Web of Science ®Google Scholar
• AyakiMSodaMYaguchiSIwasawaAKoideRCytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free eye drops in four corneoconjunctival cell linesClin Ophthalmol
   Google Scholar
• AyakiMIwasawaAYaguchiSKoideRPreserved and unpreserved 12 anti-allergic eye drops and ocular surface toxicity: in vitro assessment in four cultured corneal and conjunctival epithelial cell linesBiocontrol Sci
   Google Scholar
• AyakiMIwasawaACytotoxicity of prostaglandin analogue eye drops (tafluprost, latanoprost, travoprost, and unoproston) preserved with benzalkonium chloride in multiple corneoconjunctival cell linesClin Ophthalmol
   Google Scholar
• LiuHRoutleyITeichmannKDToxic endothelial cell destruction from intraocular benzalkonium chlorideJ Cataract Refract Surg2001271746175011709246
   PubMed Web of Science ®Google Scholar
• EleftheriadisHCheongMSandemanSCorneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgeryBr J Ophthalmol200286329930511864888
   PubMed Web of Science ®Google Scholar
• HughesEHPretoriusMEleftheriadisHLiuCSLong-term recovery of the human corneal endothelium after toxic injury by benzalkonium chlorideBr J Ophthalmol200791111460146317504856
   PubMed Web of Science ®Google Scholar
• LempMAZimmermanLEToxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chlorideAm J Ophthalmol19881056706733287942
   PubMed Web of Science ®Google Scholar
• LavineJBBinderPSWickhamMGAntimicrobials and the corneal endotheliumAnn Ophthalmol1979111015171528555846
   PubMedGoogle Scholar
• VareillesPSilverstoneDPlazonnetBLe DouarecJCSearsMLStoneCAComparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbitInvest Ophthalmol Vis Sci19771698799621145
   PubMed Web of Science ®Google Scholar
• AraieMTakaseMSakaiYIshiiYYokoyamaYKitagawaMBeta-adrenergic blockers: ocular penetration and binding to the uveal pigmentJpn J Ophthalmol1982262482636130180
   PubMed Web of Science ®Google Scholar
• PisellaPJFillacierKElenaPPDebbaschCBaudouinCComparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbitsOphthalmic Res2000323810657748
   PubMed Web of Science ®Google Scholar
• LassJHKhosrofSALaurenceJKHorwitzBGhoshKAdamsonsIA double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study GroupArch Ophthalmol1998116100310109715679
   PubMedGoogle Scholar
• KonowalAMorrisonJCBrownSVIrreversible corneal decompensation in patients treated with topical dorzolamideAm J Ophthalmol199912740340610218692
   PubMed Web of Science ®Google Scholar
• GiassonCJNguyenTQBoisjolyHMLeskMRAmyotMCharestMDorzolamide and corneal recovery from edema in patients with glaucoma or ocular hypertensionAm J Ophthalmol200012914415010682965
   PubMed Web of Science ®Google Scholar
• EganCAHodgeDOMcLarenJWBourneWMEffect of dorzolamide on corneal endothelial function in normal human eyesInvest Ophthalmol Vis Sci19983923299430541
   PubMed Web of Science ®Google Scholar
• InoueKOkugawaKOshikaTAmanoSInfluence of dorzolamide on corneal endotheliumJpn J Ophthalmol20034712913312738544
   PubMed Web of Science ®Google Scholar
• KahookMYNoeckerRJComparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tearsCornea20082733934318362664
   PubMed Web of Science ®Google Scholar
• GuenounJMBaudouinCRatPPaulyAWarnetJMBrignole-BaudouinFIn vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cellsInvest Ophthalmol Vis Sci2005464594459916303954
   PubMed Web of Science ®Google Scholar